Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human Somatostatin Receptor 2 ELISA Kit (AC2743)
Cat.#: ASET-1332
Specifications
Description Human Somatostatin Receptor 2 ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human Somatostatin Receptor 2 concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.28 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 5-80 ng/mL Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2526 Human Estrogen Receptor alpha ELISA Kit (AC3937) Quantitative inquiry ASET-1348 Human Luteinizing Hormone ELISA Kit (AC2759) Quantitative inquiry ASET-2243 Human Dopamine Receptor D1 ELISA Kit (AC3654) Quantitative inquiry ASET-1470 Human GCH1 ELISA Kit (AC2881) Quantitative inquiry ASET-1627 Mouse AGRP ELISA Kit (AC3038) Quantitative inquiry ASET-1692 Human LECT2 ELISA Kit (AC3103) Quantitative inquiry ASET-1463 Human Ornithine Aminotransferase ELISA Kit (AC2874) Quantitative inquiry ASET-1743 Human TMPRSS2 ELISA Kit (AC3154) Quantitative inquiry ASET-1020 Human CACNA1A ELISA Kit (AC2431) Quantitative inquiry ASET-1581 Human PLXNA3 ELISA Kit (AC2992) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket